QA: UNITED THERAPEUTICS Corp in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001082554_2021_UNITED_THERAPEUTICS_Corp.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001082554, UNITED THERAPEUTICS Corp

  xvar xval
0 AssetsCurrent 2,167,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 731,600,000
3 remainder_Assets 1,716,200,000
4 LiabilitiesCurrent 323,300,000
5 LiabilitiesNoncurrent 96,500,000
6 remainder_Liabilities 800,000,000
7 CostOfGoodsAndServicesSold 108,100,000
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 357,700,000
10 remainder_Expenses 548,000,000
11 remainder_Revenues 1,483,300,000
12 remainder_NetIncome 45,300,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,615,000,000
1 Liabilities 1,219,800,000
2 Expenses 1,013,800,000
3 Revenues 1,483,300,000
4 StockholdersEquity 3,395,200,000
5 NetIncome 514,800,000
6 ComprehensiveNetIncome 514,800,000
7 BaseVar 4,188,600,000
8 EconomicCapitalRatio 2.18

Edgar->Model Mapping

Feature Distribution

Change over Time